M&T Bank Corporation (MTB) Q1 2024 Earnings Call Transcript
https://seekingalpha.com/article/4683831-m-and-t-bank-corporation-mtb-q1-2024-earnings-call-transcript?source=feed_sector_transcripts
Apr 15, 2024 - M&T Bank Corporation (NYSE:NYSE:MTB) Q1 2024 Earnings Call Transcript April 15, 2024 8:00 AM ETCompany ParticipantsBrian Klock - Investor RelationsDaryl...
0
M&T Bank (MTB) Reports Q1 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2255223/m-t-bank-mtb-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2255223
Apr 15, 2024 - The headline numbers for M&T Bank (MTB) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Author Ethan Mollick on 4 Rules for Using AI
https://www.fool.com/investing/2024/04/16/author-ethan-mollick-on-4-rules-for-using-ai/?source=iedfolrf0000001
Apr 16, 2024 - We've also got a look at Why Disney and Nelson Peltz were both winners in the company's board fight and other market news.
0
Bears are Losing Control Over B&M European Value Retail SA Unsponsored ADR (BMRRY), Here's Why It's a 'Buy' Now
https://www.zacks.com/stock/news/2220331/bears-are-losing-control-over-b-m-european-value-retail-sa-unsponsored-adr-bmrry-here-s-why-it-s-a-buy-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2220331
Feb 02, 2024 - B&M European Value Retail SA Unsponsored ADR (BMRRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
0
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190
Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.
0
Macy's (M) Suffers a Larger Drop Than the General Market: Key Insights
https://www.zacks.com/stock/news/2228893/macy-s-m-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2228893
Feb 20, 2024 - In the most recent trading session, Macy's (M) closed at $19.26, indicating a -1.03% shift from the previous trading day.
0
Macy's, Lowe's Beat in Q4; Durable Goods Lower
https://www.zacks.com/stock/news/2232544/macy-s-lowe-s-beat-in-q4-durable-goods-lower?cid=CS-ZC-FT-ahead_of_wall_street-2232544
Feb 27, 2024 - We have some grist for the trading mill ahead of the opening bell, but it's not likely to cause any meaningful tremors from this vantage point.
0
Macy's (M) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/27/macys-m-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 27, 2024 - M earnings call for the period ending December 31, 2023.
0
Minneapolis company that provides services for M&A deals makes another acquisition of its own
https://www.startribune.com/datasite-buys-swiss-company-sherpany-ma-services/600346740/
Feb 28, 2024 - Datasite is acquiring Sherpany, a provider software to manage board room meetings and communication.
0
Cantor sees strong year ahead for oncology M&A
https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?source=feed_sector_healthcare
Mar 10, 2024 - Cantor Fitzgerald sees a strong year for oncology M&A as major drugmakers look to replenish pipelines ahead of steep patent cliffs for top-selling products. Read more here.
0
<Page 2